ERAL1 and breast cancer: In BC, SMYD2, and p300/CAMP mediate estrogen receptor-α (Erα) methylation and acetylation, respectively, to form dynamic interactive regulation, affecting the transcriptional regulation of Erα (Zhang et al., 2013).